This human insulin analogue that comes in disposable pens prefilled with 1, 1.5, or 3 mL, dosed in 10-unit increments1 binds reversibly to albumin, which extends its half-life to around 7 days. Steady ...
Bagsværd, Denmark, 21 March 2024 – Novo Nordisk today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion, recommending ...
Eating five portions of dark chocolate a week could cut the risk of Type 2 diabetes by one fifth, a Harvard study has found. The research, which tracked almost 200,000 people for an average of 25 ...
Reducing injection burden has long been a priority in diabetes care. Now, a weekly, fixed-dose combination of basal insulin and a GLP-1 receptor agonist is one step closer to approval in Europe.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results